Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Senores Pharma: Manohar Lalge, President- RnD, categorised as Senior Management Personnel

Ruchika Sharma7 Nov 2025 4:21 PM IST

Ahmedabad: Senores Pharma has announced the appointment and categorization of Manohar Lalge, President-Research and Development, as Senior...

USFDA concludes inspection with no 483 observations at Divis Labs Telangana facility

Divi's Labs elevates Nimmagadda Venkata Anirudh as President (Nutraceuticals)

Ruchika Sharma7 Nov 2025 3:36 PM IST

Telangana: Divi's Labs has elevated Nimmagadda Venkata Anirudh as President (Nutraceuticals) and Senior Management Personnel.He will be...

USFDA approves Caplin Steriles pain management injection

Alembic Pharma bags USFDA nod for blood cancer drug Dasatinib

Ruchika Sharma7 Nov 2025 2:54 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration...

Alembic Pharma secures USFDA approval for Travoprost Ophthalmic Solution

Alembic Pharma converts UAE branch office into wholly owned subsidiary

Ruchika Sharma7 Nov 2025 11:30 AM IST

Vadodara: Alembic Pharma has announced that the Company's Branch office in the United Arab Emirates has been converted into a Wholly Owned Subsidiary...

Big investment push: Sun Pharma Labs to set up Rs 3000 crore facility in MP

Sun Pharma open to enhance manufacturing footprint in US

Ruchika Sharma6 Nov 2025 5:15 PM IST

New Delhi: Sun Pharma has kept its options open on enhancing its manufacturing footprint in the U.S., even as the U.S. administration's 100%...

Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in Chile

Q2 results: Aurobindo Pharma net profit rises 4 percent to Rs 848 crore

Ruchika Sharma6 Nov 2025 3:06 PM IST

New Delhi: Hyderabad-based pharmaceutical giant Aurobindo Pharma Limited has reported a 4 percent jumpin consolidated net profit to Rs 848 crore...

Lupin gets seven USFDA observations for Goa facility

Senores Pharma arm facility gets USFDA EIR

Ruchika Sharma6 Nov 2025 1:55 PM IST

Senores Pharma has announced that the United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for...

Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP Trial

Sun Pharma net profit up 3 percent at Rs 3118 crore in Q2

Ruchika Sharma6 Nov 2025 1:00 PM IST

New Delhi: Pharma leader Sun Pharmaceutical Industries has recorded a Rs 3,118 crore net profit in Q2 FY26, up 2.56 percent, as India and...

Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDA

Zydus gets USFDA Orphan Drug Designation for Desidustat for beta-thalassemia

Ruchika Sharma6 Nov 2025 12:00 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the United States Food and Drug Administration (USFDA) has...

Lupin gets USFDA EIR for Pithampur Unit 3 facility

Ruchika Sharma6 Nov 2025 11:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...

Venus Remedies expands presence in Vietnam with marketing nods for Methotrexate, Cefuroxime, Irinotecan

Ruchika Sharma6 Nov 2025 10:15 AM IST

Venus Remedies Limited has received new marketing authorizations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam. These regulatory approvals...

Alembic Pharma net profit up 21 percent at Rs 185 crore in Q2

Ruchika Sharma5 Nov 2025 4:13 PM IST

New Delhi: Alembic Pharmaceuticals Ltd has reported a 21 percent year-on-year rise in consolidated net profit to Rs 185 crore for the quarter ended...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok